Overview

Phase Ib of Recombinant Human Albumin Injection

Status:
Completed

Trial end date:
2020-10-25

Target enrollment:

Participant gender:

Summary

A Randomized, Multicenter,Open-label, positive-controlled, Multi-dose Phase 1 Study to Evaluate the Safety, Tolerance,Efficacy, Pharmacokinetics and Immunogenicity of recombinant human albumin injection in Patients With Hepatic Cirrhosis

Phase:

Phase 1

Details

Lead Sponsor:

First Hospital of Jilin University
The First Hospital of Jilin University